FDA Inspection 1028763 — American Red Cross Blood Serv
The FDA completed an inspection of American Red Cross Blood Serv on October 3, 2017 in Rochester, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 3, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Rochester, NY (United States)